A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.
Senti has a proprietary synthetic biologysynthetic biology platform for development of therapeutics. The company uses genetic circuits to program cell therapies so that they have localized action, sensors, dynamic responses and safety control. Senti has a design platform for synthetic gene circuits for fast design, building and testing of therapeutic circuits.